Enveric Biosciences, Inc.
ENVB
$1.27
$0.010.79%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -32.44% | -2.05% | -27.07% | -50.54% | -49.40% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -30.75% | 1.01% | -62.29% | -55.30% | -65.76% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -99.94% | -71.26% | 112.15% | 351.82% | -- |
Total Current Assets | -41.25% | -23.65% | -25.55% | -37.98% | -44.55% |
|
|||||
Total Current Assets | -41.25% | -23.65% | -25.55% | -37.98% | -44.55% |
Net Property, Plant & Equipment | -40.89% | -39.73% | -31.81% | -33.02% | -33.11% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -79.99% | -66.65% | -57.13% | -50.01% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -42.35% | -28.31% | -27.63% | -38.25% | -44.17% |
|
|||||
Total Accounts Payable | -63.88% | -57.20% | -47.52% | -62.75% | 3.34% |
Total Accrued Expenses | 32.98% | 25.25% | -72.66% | -77.38% | -63.64% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -87.25% | -94.28% | -99.55% | -99.69% | -91.06% |
Total Other Current Liabilities | -87.25% | -94.28% | -99.55% | -99.69% | -91.06% |
Total Current Liabilities | -49.98% | -36.43% | -79.94% | -86.90% | -46.65% |
|
|||||
Total Current Liabilities | -49.98% | -36.43% | -79.94% | -86.90% | -46.65% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -49.98% | -36.43% | -79.94% | -86.90% | -46.65% |
|
|||||
Common Stock & APIC | 6.40% | 7.36% | 11.84% | 11.65% | 11.77% |
Retained Earnings | -9.40% | -9.92% | -10.59% | -11.74% | -17.97% |
Treasury Stock & Other | -8.37% | 75.10% | 0.11% | -3.74% | -3.18% |
Total Common Equity | -39.56% | -18.58% | 62.23% | 10.91% | -37.71% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -39.56% | -18.58% | 62.23% | 10.91% | -37.71% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -39.56% | -18.58% | 62.23% | 10.91% | -43.21% |
|